Mereo BioPharma Group plc Lessee, Operating Lease, Liability, to be Paid in USD from Q2 2024 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Mereo BioPharma Group plc quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q2 2024 to Q3 2025.
  • Mereo BioPharma Group plc Lessee, Operating Lease, Liability, to be Paid for the quarter ending September 30, 2025 was $410K, a 66.6% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)

Mereo BioPharma Group plc Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $410K -$816K -66.6% Sep 30, 2025 10-Q 2025-11-10
Q2 2025 $627K -$724K -53.6% Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $790K Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $958K Dec 31, 2024 10-K 2025-03-26
Q3 2024 $1.23M Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.35M Jun 30, 2024 10-Q 2024-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.